Small Interfering News Today

Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights &...

/PRNewswire/ -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...

CHICAGO, March 15, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Transfection Reagent and Equipment Market" The report offers an extensive analysis

/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Transfection Reagent and Equipment Market" The report offers an extensive...

/PRNewswire/ -- The Global Small Interfering RNA (SiRNA) Market size is projected to be $964.17 Million by 2030 growing at a CAGR of 8.6% from 2023 to 2030, as...

Olpasiran can significantly reduce lipoprotein(a) levels through small RNA interference.

Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights &...

/PRNewswire/ -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast...

DUBLIN--(BUSINESS WIRE)--The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.The report provides an in-depth analysis of the Global RNAi therapeutics mark...

Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).